GL1X · GenesisL1 explorer

MolNFT v1 · #140720 · protein

Human chymase in complex with 3-(ethoxyimino)-7-oxo-1,4-diazepane derivative

5YJP: “Human chymase in complex with 3-(ethoxyimino)-7-oxo-1,4-diazepane derivative”. X-ray diffraction, 3 ligands (8W6, NAG, ZN), 1 pocket (best druggability 0.48). MolNFT v1 #140720 on GenesisL1: 3D structure, binding sites and pockets…

PDB
5YJP
Type
protein
Length
220 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human chymase
Ligands
8W6, NAG, ZN
Pockets
1 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 9% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHuman chymaseprotein2209% helix, 39% strand—

Ligands and binding sites

  • 8W6 · 4-((R)-1-((R,Z)-6-(5-chloro-2-methoxybenzyl)-3-(ethoxyimino)-7-oxo-1,4-diazepane-1-carboxamido) propyl)benzoic acid · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1880.480.82208W6

Modifications

Observed in the structure: 3 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 5YJP · Human chymase in complex with 3-(ethoxyimino)-7-oxo-1,4-diazepane derivative · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.